Nuveen Asset Management, LLC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 98 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$713,000
-54.6%
147,252
-0.3%
0.00%
-100.0%
Q4 2019$1,569,000
+2.1%
147,6820.0%0.00%0.0%
Q3 2019$1,537,000
-21.9%
147,682
+15.0%
0.00%0.0%
Q2 2019$1,968,000128,4590.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
QVT Financial LP 220,000$9,965,0000.68%
Healthcare Value Capital, LLC 16,464$746,0000.65%
EAM Investors, LLC 69,151$3,132,0000.62%
Baker Brothers Advisors 800,400$36,255,0000.52%
Spark Investment Management LLC 38,300$1,733,0000.40%
Perceptive Advisors 180,416$8,172,0000.34%
SIGMA CAPITAL MANAGEMENT LLC 175,000$7,926,0000.33%
DRIEHAUS CAPITAL MANAGEMENT LLC 129,915$5,885,0000.23%
Visium Asset Management, LP 150,000$6,794,0000.15%
ESSEX INVESTMENT MANAGEMENT CO LLC 19,732$894,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders